Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Given the high global prevalence of obesity and its strong association with type 2 diabetes and other chronic diseases, GLP-3 emerges as a highly promising research candidate
DOI: 10.1007/s00394-014-0706-z
Based on our study, a GLP-1 receptor agonist-based weight-loss program appears to be superior to non-GLP-1 receptor agonist-based weight-loss programs and intensive lifestyle modification alone for treating post-bariatric surgery weight regain, regardless of surgery type, the researchers wrote
Its role, however, extends beyond merely controlling blood sugar
US$ 21.36
US$ 24.96
US$ 20.93
US$ 21.73
US$ 20.89
US$ 29.55
